BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meijer B, Mulder CJ, van Bodegraven AA, de Boer NKH. How I treat my inflammatory bowel disease-patients with thiopurines? World J Gastrointest Pharmacol Ther 2016; 7(4): 524-530 [PMID: 27867685 DOI: 10.4292/wjgpt.v7.i4.524]
URL: https://www.wjgnet.com/2150-5349/full/v7/i4/524.htm
Number Citing Articles
1
Hong-Hui Wang, Ying He, Hong-Xian Wang, Cheng-Ling Liao, Yu Peng, Li-Jian Tao, Wei Zhang, Hui-Xiang Yang. Comparison of <i>TPMT</i> and <i>NUDT15</i> polymorphisms in Chinese patients with inflammatory bowel diseaseWorld Journal of Gastroenterology 2018; 24(8): 941-948 doi: 10.3748/wjg.v24.i8.941
2
Debbie S. Deben, Dennis R. Wong, Adriaan A. van Bodegraven. Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel diseaseExpert Opinion on Drug Metabolism & Toxicology 2022; : 1 doi: 10.1080/17425255.2021.2029406
3
Femke Crouwel, Hans J. C. Buiter, Nanne K. Boer. Discontinuation rate of azathioprineLiver International 2020; 40(12): 3141 doi: 10.1111/liv.14574
4
Ahmed B. Bayoumy, Melek Simsek, Margien L. Seinen, Chris J.J. Mulder, Azhar Ansari, Godefridus J. Peters, Nanne K. De Boer. The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive reviewExpert Opinion on Drug Metabolism & Toxicology 2020; : 1 doi: 10.1080/17425255.2020.1719996
5
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828